Publications
5808 Results
- Journal / Conference
- Journal of Clinical Oncology 32:5s (suppl; abstr LBA1); ASCO Annual Meeting (May 30-June 3, 2014, Chicago, IL), LBA scientific plenary session (oral);
- Year
- 2014
- Research Committee(s)
- Breast and Cancer Survivorship
Randomized comparison of adjuvant treatment with aromatase inhibitor (AI) exemestane (E) plus ovarian function suppression (OFS) versus tamoxifen (T) plus OFS in premenopausal women with hormone receptor-positive (HR+) breast cancer (BC): joint analysis of TEXT and SOFT
- Journal / Conference
- International Society for Quality of Life Research annual meeting (Berlin, Germany, Oct. 15-18, 2014); oral presentation;
- Year
- 2014
- Research Committee(s)
- Cancer Control, Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000, SWOG-9217
Health-related quality of life outcomes in prostate cancer prevention clinical trials
- Journal / Conference
- Urology 84(1):127-131;
- Year
- 2014
- Research Committee(s)
- Cancer Control
- PMID
- PMID24824408
- PMC
- PMC4077907
- Study Number(s)
- SWOG-9217
Androgen receptor CAG repeat length and TMPRSS2:ETS prostate cancer risk: results from the Prostate Cancer Prevention Trial
- Journal / Conference
- Nature Genetics 46(9):994-1000;
- Year
- 2014
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID25086665
- PMC
- PMC4191666
- Study Number(s)
- S0000
Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer
- Journal / Conference
- Cancer 120(21):3329-3337;
- Year
- 2014
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID25041994
- PMC
- PMC4259283
- Study Number(s)
- SWOG-9304 (INT-0144)
Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among stage II or III rectal cancer patients (INT-0144; SWOG 9304)
- Journal / Conference
- Journal of Clinical Oncology, 32(22):2311-2317; accepted 2/27/14
- Year
- 2014
- Research Committee(s)
- Breast
- PMID
- PMID24934787
- PMC
- PMC4105484
Comparison of doxorubicin and cyclophosphamide (AC) versus single agent paclitaxel (T) as adjuvant therapy for breast cancer in women with 0-3 positive axillary nodes: CALGB 40101 (Alliance)
- Journal / Conference
- Journal of Clinical Oncology 32(31):3483-3489;
- Year
- 2014
- Research Committee(s)
- Breast
- PMID
- PMID24888818
- PMC
- PMC4209100
- Study Number(s)
- S0500
SWOG S0500: circulating tumor cells and response to chemotherapy in metastatic breast cancer
- Journal / Conference
- Journal of Clinical Oncology 32(6):587-600
- Year
- 2014
- Research Committee(s)
- Myeloma
- PMID
- PMID24419113
- PMC
- PMC3918540
International myeloma working group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation
- Journal / Conference
- Leukemia 28(3):525-542
- Year
- 2014
- Research Committee(s)
- Myeloma
- PMID
- PMID24253022
- PMC
- PMC4143389
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)
- Journal / Conference
- Clinical Colorectal Cancer 13(2):100-109;
- Year
- 2014
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID24512953
- PMC
- PMC4019685
- Study Number(s)
- CTSU/N0147